Follow-up of the non-interventional TARGET study – efficacy and safety of nilotinib in routine clinical management of CML patients (pts) failing prior therapy

Stegelmann, F., Dengler, J., Le Coutre, P., Mueller, M. C., Sauer, A., Schwinger, U., Losem, C., Schneider-Kappus, W., Stern, S., Vehling-Kaiser, U., Meincke, M., Frank, O. and Ottmann, Oliver ORCID: https://orcid.org/0000-0001-9559-1330 2014. Follow-up of the non-interventional TARGET study – efficacy and safety of nilotinib in routine clinical management of CML patients (pts) failing prior therapy. Oncology Research and Treatment 37 (Supp 1) , p. 84.

Full text not available from this repository.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Schools > Medicine
Subjects:	R Medicine > R Medicine (General)
Publisher:	Karger Publishers
ISSN:	2296-5270
Last Modified:	02 Nov 2022 09:55
URI:	https://orca.cardiff.ac.uk/id/eprint/96801

Actions (repository staff only)

Edit Item